Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP - 17): Their relevance for understanding the neurogenerative process

Michel Goedert, Bernardino Ghetti, Maria Grazia Spillantini

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Tau is a microtubule-associated protein that binds to microtubules and promotes microtubule assembly. Six tau isoforms are produced in adult human brain by alternative mRNA splicing from a single gene. Inclusion of a 31 amino acid repeat encoded by exon 10 of the tau gene gives rise to the three isoforms with four microtubule-binding repeats each. The other three tau isoforms have three repeats each. Abundant neurofibrillary lesions made of tau protein constitute a defining neuropathological characteristic of Alzheimer's disease. Filamentous tau protein deposits are also the defining characteristic of other neurodegenerative diseases, many of which are frontotemporal dementias or movement disorders, such as Pick's disease, progressive supranuclear palsy, and corticobasal degeneration. It is well established that the distribution of tau pathology correlates with the presence of symptoms of disease. However, until recently, there was no genetic evidence linking tau to neurodegeneration. This has now changed with the discovery of more than 15 mutations in the tau gene in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). The new work has shown that dysfunction of tau protein causes neurodegeneration.

Original languageEnglish
Pages (from-to)74-83
Number of pages10
JournalAnnals of the New York Academy of Sciences
Volume920
StatePublished - 2000

Fingerprint

tau Proteins
Frontotemporal Dementia
Chromosomes, Human, Pair 17
Parkinsonian Disorders
Chromosomes
Microtubules
Protein Isoforms
Genes
Mutation
Pick Disease of the Brain
Neurodegenerative diseases
Progressive Supranuclear Palsy
Microtubule-Associated Proteins
Movement Disorders
Alternative Splicing
Pathology
Neurodegenerative Diseases
Exons
Brain
Alzheimer Disease

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

@article{3d5989f4a6cb40758241fdfb0b24b632,
title = "Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP - 17): Their relevance for understanding the neurogenerative process",
abstract = "Tau is a microtubule-associated protein that binds to microtubules and promotes microtubule assembly. Six tau isoforms are produced in adult human brain by alternative mRNA splicing from a single gene. Inclusion of a 31 amino acid repeat encoded by exon 10 of the tau gene gives rise to the three isoforms with four microtubule-binding repeats each. The other three tau isoforms have three repeats each. Abundant neurofibrillary lesions made of tau protein constitute a defining neuropathological characteristic of Alzheimer's disease. Filamentous tau protein deposits are also the defining characteristic of other neurodegenerative diseases, many of which are frontotemporal dementias or movement disorders, such as Pick's disease, progressive supranuclear palsy, and corticobasal degeneration. It is well established that the distribution of tau pathology correlates with the presence of symptoms of disease. However, until recently, there was no genetic evidence linking tau to neurodegeneration. This has now changed with the discovery of more than 15 mutations in the tau gene in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). The new work has shown that dysfunction of tau protein causes neurodegeneration.",
author = "Michel Goedert and Bernardino Ghetti and Spillantini, {Maria Grazia}",
year = "2000",
language = "English",
volume = "920",
pages = "74--83",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP - 17)

T2 - Their relevance for understanding the neurogenerative process

AU - Goedert, Michel

AU - Ghetti, Bernardino

AU - Spillantini, Maria Grazia

PY - 2000

Y1 - 2000

N2 - Tau is a microtubule-associated protein that binds to microtubules and promotes microtubule assembly. Six tau isoforms are produced in adult human brain by alternative mRNA splicing from a single gene. Inclusion of a 31 amino acid repeat encoded by exon 10 of the tau gene gives rise to the three isoforms with four microtubule-binding repeats each. The other three tau isoforms have three repeats each. Abundant neurofibrillary lesions made of tau protein constitute a defining neuropathological characteristic of Alzheimer's disease. Filamentous tau protein deposits are also the defining characteristic of other neurodegenerative diseases, many of which are frontotemporal dementias or movement disorders, such as Pick's disease, progressive supranuclear palsy, and corticobasal degeneration. It is well established that the distribution of tau pathology correlates with the presence of symptoms of disease. However, until recently, there was no genetic evidence linking tau to neurodegeneration. This has now changed with the discovery of more than 15 mutations in the tau gene in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). The new work has shown that dysfunction of tau protein causes neurodegeneration.

AB - Tau is a microtubule-associated protein that binds to microtubules and promotes microtubule assembly. Six tau isoforms are produced in adult human brain by alternative mRNA splicing from a single gene. Inclusion of a 31 amino acid repeat encoded by exon 10 of the tau gene gives rise to the three isoforms with four microtubule-binding repeats each. The other three tau isoforms have three repeats each. Abundant neurofibrillary lesions made of tau protein constitute a defining neuropathological characteristic of Alzheimer's disease. Filamentous tau protein deposits are also the defining characteristic of other neurodegenerative diseases, many of which are frontotemporal dementias or movement disorders, such as Pick's disease, progressive supranuclear palsy, and corticobasal degeneration. It is well established that the distribution of tau pathology correlates with the presence of symptoms of disease. However, until recently, there was no genetic evidence linking tau to neurodegeneration. This has now changed with the discovery of more than 15 mutations in the tau gene in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). The new work has shown that dysfunction of tau protein causes neurodegeneration.

UR - http://www.scopus.com/inward/record.url?scp=0034528413&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034528413&partnerID=8YFLogxK

M3 - Article

C2 - 11193179

AN - SCOPUS:0034528413

VL - 920

SP - 74

EP - 83

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

ER -